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GliomaAbstract Demyelinating pseudotumors are rare, benign, solitary intracranial space occupying
lesions which masquerade cerebral neoplasms. Contrast MRI shows open ring enhancement which
is fairly speciﬁc for this entity. Advanced MRI techniques like MR spectroscopy and magnetizing
transfer techniques can help differentiating these lesions. NAA/Cr ratio is signiﬁcantly elevated in
central regions of demyelinating pseudotumors than in gliomas and other lesions. Presence of abun-
dant foamy macrophages, lymphoid inﬂammatory inﬁltrates around blood vessels, sheets of gemist-
ocytic astrocytes with well-developed processes, well deﬁned border of the lesion absence of
neovascularity and necrosis should help us diagnose demyelinating pseudotumor fairly conﬁdently
on histopathology.
 2014 The Egyptian Society of Radiology and Nuclear Medicine. Production and hosting by Elsevier
B.V. All rights reserved.1. Introduction
Demyelinating pseudotumors are rare, benign, solitary intra-
cranial space occupying lesions which masquerade brain
neoplasms clinically, radiologically and histopathologically(1–7). It is very difﬁcult to differentiate these lesions from
brain tumors as there is a considerable clinico-radiological
overlap and it becomes nearly impossible to differentiate
on routine cross sectional imaging when they present with
hemorrhage or show complete rim enhancement (1,3,4,8).
Subsequent relapse of symptoms and the presence of multi-
ple abnormal signal intensity plaques, should raise suspicion
of demyelinating pseudotumor (5). We describe a case of
43 year old female who presented to us with left parietal
lobe hemorrhagic lesion which we initially presumed as gli-
oma but biopsy revealed inﬂammatory demyelinating
pseudotumor.ed.
138 A. Agrawal et al.2. Case report
A 43 year old female came to the emergency department with
the history of sudden onset of loss of consciousness followed
by generalized tonic-clonic seizures. On admission, her vitals
were stable (Blood pressure – 146/90). Patient was not a
known hypertensive or diabetic. She had recent complaints
of febrile illness, headache, weight loss and weakness for which
was admitted in local rural hospital and was treated. Appar-
ently she worsened during treatment and she was referred to
our hospital. On examination – pupils were normal and react-
ing to light, motor examination showed decreased power in
right upper and lower limbs, plantar reﬂex was extensor on
right side, sensory examination was unremarkable and lab
investigations were within normal limits. MRI brain showed
a 5 · 6 cm T1 hyperintense and T2 heterogenous signal inten-
sity lesion in the left parietal lobe with extensive perilesional
vasogenic edema (Figs. 1 and 2) and ovoid hyperintensities
in periventricular white matter (Fig. 2). On contrast adminis-
tration, there was complete rim enhancement of the lesion
(Fig. 3). Initial differentials thought were glioma and venousFig. 1 Axial T2 weighted MR image showing large heterogenou
hypointense hemosiderin rim, perilesional extensive vasogenic edem
perpendicular hyperintense lesions in right frontal lobe suggestive of dinfarct however later was ruled out as venous sinus ﬂow voids
were maintained. Presuming the lesion as glioma, right parietal
craniotomy and excision was performed and the specimen was
sent for histopathological examination. Sections showed
numerous vascular channels dissecting into the parenchyma;
vascular channels were lined by prominent endothelial cells
and surrounded by scattered spindle cells. Scanty areas of
necrosis were seen surrounded by golden yellow pigment rep-
resenting hemosiderin. Numerous foamy macrophages were
also noted. These features were consistent with demyelinating
pseudotumor. Patient was given high dose corticosteroids and
she recovered drastically from weakness (see Fig. 4).
3. Discussion
Inﬂammatory demyelinating pseudotumor (IDMP) is a puzzle
to clinicians, radiologists and pathologists due to many over-
lapping features (1,3–5,7). Pathogenesis of IDMPs is not clear
and it is different from multiple sclerosis and acute dissemi-
nated encephalomyelitis (9). Patients with IDMP or brain
tumors can present with frequent headaches, giddiness, altereds predominantly hyperintense left parietal lobe lesion showing
a and mild midline shift to right. Also note the periventricular
emyelination foci.
Fig. 2 Axial T1W image (A) showing hyperintense lesion in right parietal lobe suggestive of hemorrhage, coronal FLAIR and sagittal
T2W images (B, C) showing heterogeneous signal intensity of lesion and sagittal T2W image (D) in right parasagittal location showing
multiple hyperintense signal intensity lesions arranged perpendicular to the ventricle – consistent with demyelinating plaques.
Fig. 3 Contrast T1W image showing complete rim enhancement of the lesion.
Fig. 4 Immediate post operative axial CT image showing signiﬁcant reduction in size of lesion, however edema and mass effect were
persistent.
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(3). Radiologically, IDMPs apart from mimicking primary
brain tumors, also simulate infective and metastatic masses.
Conventional MRI techniques usually fail to differentiate
these entities (1,4). On contrast MRI majority of IDMPs when
active show open ring enhancement along the progressive edge
usually toward gray matter side of the lesion (1,4,8). Advanced
MRI techniques like MR spectroscopy and magnetizing trans-
fer techniques can help differentiate these lesions. NAA/Cr
ratio is signiﬁcantly elevated in central regions of IDMPs than
in gliomas and other lesions. IDMPs have lower magnetizing
transfer values and low regional cerebral blood volume (rCBV)
on perfusion studies (1,4). Unfortunately we could not perform
any of these advanced MRI sequences in our case because of
patient’s poor compliance. However, retrospectively we could
identify ovoid periventricular hyperintense demyelinating pla-
ques on sagittal T2W images adjacent to corpus callosum
which we initially ignored as white matter ischemic changes.
Histopathologically, hypercellularity of demyelinating plaque
during the active stage resembles the hypercellularity of neo-
plastic lesions; however both can be differentiated by the pres-
ence of abundant pleomorphic astrocytes and bizarre nuclei in
later. Presence of abundant foamy macrophages, lymphoid
inﬂammatory inﬁltrates around blood vessels, sheets of gemist-
ocytic astrocytes with well-developed processes, well deﬁned
border of the lesion absence of neovascularity and necrosis
should help us diagnose IDMPs (3,9,10). The cause for hemor-
rhage in IDMPs remains unclear. However the mechanism
may be similar to as aquaporin antibody (AQP4-Ab) related
destruction as in neuromyelitis optica where breeches in the
integrity of the blood brain barrier result in perivascular
inﬂammation subsequently resulting in intracranial hemor-
rhage (11). It is always advisable to perform biopsy even if
slight suspicion exists as treatment drastically differs for both
entities (4). IDMPs respond very well to high dose steroids
as compared to brain tumors (3,5). It is important to note that
radiation given to suppress neoplastic process can aggravate
demyelination (4).
4. Conclusion
It is always advisable to the clinician and radiologist to keep in
mind differential of inﬂammatory demyelinating pseudotumor
for any mass lesion showing minimal vasogenic edema, mass
effect disproportionate to its size. Numerous challenges exist
because it is very difﬁcult to convince one self and others
to give this rarer diagnosis overruling relatively common
diagnosis of brain neoplasm. Though considerable clinico-radiological overlap exists the presence of multiple abnormal
periventricular white matter signal intensities, increased appar-
ent diffusion coefﬁcient values, high NAA/Cr ratio in center of
the lesion on MR spectroscopy, low magnetizing transfer val-
ues, low regional cerebral perfusion and open ring enhance-
ment, one should favor the diagnosis of demyelinating
pseudotumor (1). It is always advisable to perform biopsy even
if slight suspicion exists as treatment drastically differs between
both entities.Conﬂict of interest
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